Streptokinase Injection Dilution Protocol
Streptokinase should be administered as 1.5 million units diluted in 100 mL of normal saline and infused intravenously over 30-60 minutes for acute myocardial infarction. 1, 2
Dilution and Administration Procedure
For Acute Myocardial Infarction
- Reconstitute streptokinase powder with the appropriate diluent as per manufacturer's instructions
- Dilute the reconstituted streptokinase to a total volume of 100 mL with normal saline
- Administer the 1.5 million units intravenously over 30-60 minutes 1
- Some evidence suggests that more rapid infusion (20 minutes) may lead to higher reperfusion rates (80% vs 58% with standard 60-minute infusion) 3
For Arterial Thrombosis
- For selective intra-arterial infusion: 5,000 units/hour for 24-48 hours 4, 5
- Often administered with concurrent heparin (250-500 units/hour) 4
For Prosthetic Valve Thrombosis
- Initial bolus: 250,000 units given over 30 minutes
- Followed by continuous infusion: 100,000 units/hour 1
- Duration depends on clinical response (typically 2-72 hours)
Monitoring During Administration
- Monitor hemodynamic parameters every 2-3 hours during infusion
- For obstructive prosthetic valve thrombosis, perform Doppler echocardiography every 2-3 hours
- For non-obstructive cases, perform TEE at 24 hours and repeat at 48 and 72 hours if thrombus persists
- Monitor for lytic state: increased D-dimer and aPTT, decreased fibrinogen 1
Important Precautions
Contraindications
- Prior streptokinase exposure within the past 6 months (absolute contraindication) 1, 2
- History of streptococcal pharyngitis within past 6 months 1
- Other standard contraindications for thrombolytic therapy include:
- Active bleeding or bleeding diathesis
- Recent stroke (within 3 months)
- Intracranial or intraspinal surgery within 2 months
- Suspected aortic dissection
- Significant head/facial trauma within 3 months 1
Adjunctive Medications
- Administer aspirin (150-325 mg orally or 250-500 mg IV) before streptokinase 2
- For STEMI, add clopidogrel (300 mg loading dose if ≤75 years; 75 mg if >75 years) 2
- Anticoagulation should be administered with streptokinase:
Clinical Pearls
- Streptokinase is non-fibrin specific and achieves 60-68% patency rates (TIMI 2-3 flow) at 90 minutes, which is lower than fibrin-specific agents like alteplase (73-84%) or tenecteplase (85%) 1, 2
- Streptokinase antibodies can persist for years after exposure, potentially reducing efficacy and increasing allergic reaction risk 2
- For prosthetic valve thrombosis, if there's no hemodynamic improvement after 24 hours or after 72 hours even without complete recovery, consider stopping the infusion 1
- If streptokinase fails due to antibodies, consider switching to urokinase 1
- Surgery can be performed 24 hours after discontinuation of streptokinase infusion 1
By following this protocol, you can safely and effectively administer streptokinase for thrombolysis in appropriate clinical scenarios while minimizing complications.